• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过Wnt阻断抗体进行表位作图:硫酸乙酰肝素中Wnt结合域的证据。

Epitope mapping by a Wnt-blocking antibody: evidence of the Wnt binding domain in heparan sulfate.

作者信息

Gao Wei, Xu Yongmei, Liu Jian, Ho Mitchell

机构信息

Laboratory of Molecular Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.

Key Laboratory of Human Functional Genomics of Jiangsu Province, Department of Cell Biology, School of Basic Medical Science, Nanjing Medical University, Nanjing, Jiangsu, 210029, China.

出版信息

Sci Rep. 2016 May 17;6:26245. doi: 10.1038/srep26245.

DOI:10.1038/srep26245
PMID:27185050
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4869111/
Abstract

Heparan sulfate (HS) is a polysaccharide known to modulate many important biological processes, including Wnt signaling. However, the biochemical interaction between HS and Wnt molecules is not well characterized largely due to the lack of suitable methods. To determine the Wnt binding domain in HS, we used a Wnt signaling-inhibitory antibody (HS20) and a panel of synthetic HS oligosaccharides with distinct lengths and sulfation modifications. We found that the binding of HS20 to heparan sulfate required sulfation at both the C2 position (2-O-sulfation) and C6 position (6-O-sulfation). The oligosaccharides with the greatest competitive effect for HS20 binding were between six and eight saccharide residues in length. Additionally, a four residue-long oligosaccharide could also be recognized by HS20 if an additional 3-O-sulfation modification was present. Furthermore, similar oligosaccharides with 2-O, 6-O and 3-O-sulfations showed inhibition for Wnt activation. These results have revealed that HS20 and Wnt recognize a HS structure containing IdoA2S and GlcNS6S, and that the 3-O-sulfation in GlcNS6S3S significantly enhances the binding of both HS20 and Wnt. This study provides the evidence for identifying the Wnt binding domain in HS and suggests a therapeutic approach to target the interaction of Wnt and HS in cancer and other diseases.

摘要

硫酸乙酰肝素(HS)是一种已知可调节许多重要生物过程的多糖,包括Wnt信号传导。然而,由于缺乏合适的方法,HS与Wnt分子之间的生化相互作用尚未得到很好的表征。为了确定HS中的Wnt结合结构域,我们使用了一种Wnt信号抑制抗体(HS20)和一组具有不同长度和硫酸化修饰的合成HS寡糖。我们发现HS20与硫酸乙酰肝素的结合需要在C2位置(2-O-硫酸化)和C6位置(6-O-硫酸化)都进行硫酸化。对HS20结合具有最大竞争效应的寡糖长度在6至8个糖残基之间。此外,如果存在额外的3-O-硫酸化修饰,一个四残基长的寡糖也可以被HS20识别。此外,具有2-O、6-O和3-O-硫酸化的类似寡糖对Wnt激活有抑制作用。这些结果表明,HS20和Wnt识别含有艾杜糖醛酸2-硫酸酯(IdoA2S)和N-乙酰葡糖胺6-硫酸酯(GlcNS6S)的HS结构,并且GlcNS6S3S中的3-O-硫酸化显著增强了HS20和Wnt的结合。这项研究为鉴定HS中的Wnt结合结构域提供了证据,并提出了一种针对癌症和其他疾病中Wnt与HS相互作用的治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0206/4869111/71a8a155d747/srep26245-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0206/4869111/80e1ce1b514a/srep26245-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0206/4869111/a59233b205f3/srep26245-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0206/4869111/f91401a5d695/srep26245-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0206/4869111/22971259bf6e/srep26245-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0206/4869111/7555ea881a24/srep26245-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0206/4869111/de71eae5a2de/srep26245-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0206/4869111/71a8a155d747/srep26245-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0206/4869111/80e1ce1b514a/srep26245-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0206/4869111/a59233b205f3/srep26245-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0206/4869111/f91401a5d695/srep26245-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0206/4869111/22971259bf6e/srep26245-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0206/4869111/7555ea881a24/srep26245-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0206/4869111/de71eae5a2de/srep26245-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0206/4869111/71a8a155d747/srep26245-f7.jpg

相似文献

1
Epitope mapping by a Wnt-blocking antibody: evidence of the Wnt binding domain in heparan sulfate.通过Wnt阻断抗体进行表位作图:硫酸乙酰肝素中Wnt结合域的证据。
Sci Rep. 2016 May 17;6:26245. doi: 10.1038/srep26245.
2
Human Monoclonal Antibody Targeting the Heparan Sulfate Chains of Glypican-3 Inhibits HGF-Mediated Migration and Motility of Hepatocellular Carcinoma Cells.靶向磷脂酰肌醇蛋白聚糖-3硫酸乙酰肝素链的人单克隆抗体抑制肝细胞生长因子介导的肝癌细胞迁移和运动能力
PLoS One. 2015 Sep 2;10(9):e0137664. doi: 10.1371/journal.pone.0137664. eCollection 2015.
3
Inactivation of Wnt signaling by a human antibody that recognizes the heparan sulfate chains of glypican-3 for liver cancer therapy.一种识别聚糖蛋白 3 硫酸乙酰肝素链的人源抗体对肝癌治疗中 Wnt 信号通路的抑制作用。
Hepatology. 2014 Aug;60(2):576-87. doi: 10.1002/hep.26996. Epub 2014 Jun 18.
4
The binding properties of minimal oligosaccharides reveal a common heparan sulfate/dermatan sulfate-binding site in hepatocyte growth factor/scatter factor that can accommodate a wide variety of sulfation patterns.最小寡糖的结合特性揭示了肝细胞生长因子/分散因子中一个常见的硫酸乙酰肝素/硫酸皮肤素结合位点,该位点可容纳多种硫酸化模式。
J Biol Chem. 2009 Mar 6;284(10):6311-21. doi: 10.1074/jbc.M807671200. Epub 2008 Dec 29.
5
The 3--sulfation of heparan sulfate modulates protein binding and lyase degradation.硫酸乙酰肝素的 3-硫酸化调节蛋白结合和裂解酶的降解。
Proc Natl Acad Sci U S A. 2021 Jan 19;118(3). doi: 10.1073/pnas.2012935118.
6
QSulf1 remodels the 6-O sulfation states of cell surface heparan sulfate proteoglycans to promote Wnt signaling.QSulf1重塑细胞表面硫酸乙酰肝素蛋白聚糖的6-O硫酸化状态以促进Wnt信号传导。
J Cell Biol. 2003 Jul 21;162(2):341-51. doi: 10.1083/jcb.200212083. Epub 2003 Jul 14.
7
N-Acetylated domains in heparan sulfates revealed by a monoclonal antibody against the Escherichia coli K5 capsular polysaccharide. Distribution of the cognate epitope in normal human kidney and transplant kidney with chronic vascular rejection.抗大肠杆菌K5荚膜多糖单克隆抗体揭示的硫酸乙酰肝素中的N-乙酰化结构域。正常人类肾脏和慢性血管排斥反应移植肾中同源表位的分布。
J Biol Chem. 1996 Sep 13;271(37):22802-9. doi: 10.1074/jbc.271.37.22802.
8
Downstream Products are Potent Inhibitors of the Heparan Sulfate 2-O-Sulfotransferase.下游产物是硫酸乙酰肝素 2-O-磺基转移酶的有效抑制剂。
Sci Rep. 2018 Aug 7;8(1):11832. doi: 10.1038/s41598-018-29602-4.
9
3-O-sulfated oligosaccharide structures are recognized by anti-heparan sulfate antibody HS4C3.3-O-硫酸化寡糖结构可被抗硫酸乙酰肝素抗体HS4C3识别。
J Biol Chem. 2006 Feb 24;281(8):4654-62. doi: 10.1074/jbc.M506357200. Epub 2005 Dec 22.
10
Interaction of hepatocyte growth factor with heparan sulfate. Elucidation of the major heparan sulfate structural determinants.肝细胞生长因子与硫酸乙酰肝素的相互作用。主要硫酸乙酰肝素结构决定因素的阐明。
J Biol Chem. 1994 Apr 15;269(15):11216-23.

引用本文的文献

1
Structural Features of Glypicans and their Impact on Wnt Signaling in Cancer.磷脂酰肌醇蛋白聚糖的结构特征及其对癌症中Wnt信号传导的影响。
Proteoglycan Res. 2025 Apr;3(2). doi: 10.1002/pgr2.70029. Epub 2025 May 13.
2
Glycosaminoglycans, Instructive Biomolecules That Regulate Cellular Activity and Synaptic Neuronal Control of Specific Tissue Functional Properties.糖胺聚糖,调节细胞活性和特定组织功能特性的突触神经元控制的指导性生物分子。
Int J Mol Sci. 2025 Mar 12;26(6):2554. doi: 10.3390/ijms26062554.
3
Modeling interactions between Heparan sulfate and proteins based on the Heparan sulfate microarray analysis.

本文引用的文献

1
Human Monoclonal Antibody Targeting the Heparan Sulfate Chains of Glypican-3 Inhibits HGF-Mediated Migration and Motility of Hepatocellular Carcinoma Cells.靶向磷脂酰肌醇蛋白聚糖-3硫酸乙酰肝素链的人单克隆抗体抑制肝细胞生长因子介导的肝癌细胞迁移和运动能力
PLoS One. 2015 Sep 2;10(9):e0137664. doi: 10.1371/journal.pone.0137664. eCollection 2015.
2
Targeting the WNT Signaling Pathway in Cancer Therapeutics.癌症治疗中靶向WNT信号通路
Oncologist. 2015 Oct;20(10):1189-98. doi: 10.1634/theoncologist.2015-0057. Epub 2015 Aug 25.
3
Heparan sulfate and heparin interactions with proteins.
基于肝素硫酸微阵列分析的肝素硫酸与蛋白质相互作用的建模。
Glycobiology. 2024 May 26;34(7). doi: 10.1093/glycob/cwae039.
4
Dissection of N-deacetylase and N-sulfotransferase activities of NDST1 and their effects on Wnt8 distribution and signaling in Xenopus embryos.NDST1 的 N-脱乙酰基酶和 N-磺基转移酶活性的剖析及其对 Xenopus 胚胎中 Wnt8 分布和信号转导的影响。
Dev Growth Differ. 2024 Apr;66(3):248-255. doi: 10.1111/dgd.12915. Epub 2024 Feb 7.
5
Heparan sulfate promotes TRAIL-induced tumor cell apoptosis.肝素硫酸盐促进 TRAIL 诱导的肿瘤细胞凋亡。
Elife. 2024 Jan 24;12:RP90192. doi: 10.7554/eLife.90192.
6
The Glycosaminoglycan Side Chains and Modular Core Proteins of Heparan Sulphate Proteoglycans and the Varied Ways They Provide Tissue Protection by Regulating Physiological Processes and Cellular Behaviour.糖胺聚糖侧链和硫酸乙酰肝素蛋白聚糖的模块化核心蛋白,以及它们通过调节生理过程和细胞行为提供组织保护的多种方式。
Int J Mol Sci. 2023 Sep 14;24(18):14101. doi: 10.3390/ijms241814101.
7
Heparan sulfate promotes TRAIL-induced tumor cell apoptosis.硫酸乙酰肝素促进肿瘤坏死因子相关凋亡诱导配体(TRAIL)诱导的肿瘤细胞凋亡。
bioRxiv. 2023 Nov 1:2023.07.26.550758. doi: 10.1101/2023.07.26.550758.
8
Wnt/β-catenin signaling pathway inhibitors, glycyrrhizic acid, solanine, polyphyllin I, crocin, hypericin, tubeimoside-1, diosmin, and rutin in medicinal plants have better binding affinities and anticancer properties: Molecular docking and ADMET study.药用植物中的Wnt/β-连环蛋白信号通路抑制剂、甘草酸、茄碱、重楼皂苷I、藏红花素、金丝桃素、土贝母苷甲、地奥司明和芦丁具有更好的结合亲和力和抗癌特性:分子对接和ADMET研究
Food Sci Nutr. 2023 May 4;11(7):4155-4169. doi: 10.1002/fsn3.3405. eCollection 2023 Jul.
9
A cell transmembrane peptide chimeric M(27-39)-HTPP targeted therapy for hepatocellular carcinoma.一种用于肝细胞癌的细胞跨膜肽嵌合体M(27 - 39)-HTPP靶向治疗
iScience. 2023 Apr 29;26(5):106766. doi: 10.1016/j.isci.2023.106766. eCollection 2023 May 19.
10
Structural and Functional Impact of Posttranslational Modification of Glypican-3 on Liver Carcinogenesis.聚糖蛋白 3 的翻译为 Glypican-3
Cancer Res. 2023 Jun 15;83(12):1933-1940. doi: 10.1158/0008-5472.CAN-22-3895.
硫酸乙酰肝素和肝素与蛋白质的相互作用。
J R Soc Interface. 2015 Sep 6;12(110):0589. doi: 10.1098/rsif.2015.0589.
4
Interaction of human tumor viruses with host cell surface receptors and cell entry.人类肿瘤病毒与宿主细胞表面受体的相互作用及细胞进入
Viruses. 2015 May 22;7(5):2592-617. doi: 10.3390/v7052592.
5
Targeting Wnts at the source--new mechanisms, new biomarkers, new drugs.从源头靶向Wnts——新机制、新生物标志物、新药物。
Mol Cancer Ther. 2015 May;14(5):1087-94. doi: 10.1158/1535-7163.MCT-14-1038. Epub 2015 Apr 21.
6
Heparin/Heparan sulfate proteoglycans glycomic interactome in angiogenesis: biological implications and therapeutical use.血管生成中肝素/硫酸乙酰肝素蛋白聚糖糖组相互作用组:生物学意义与治疗应用
Molecules. 2015 Apr 10;20(4):6342-88. doi: 10.3390/molecules20046342.
7
Immunotoxin targeting glypican-3 regresses liver cancer via dual inhibition of Wnt signalling and protein synthesis.靶向磷脂酰肌醇蛋白聚糖-3的免疫毒素通过双重抑制Wnt信号传导和蛋白质合成来消退肝癌。
Nat Commun. 2015 Mar 11;6:6536. doi: 10.1038/ncomms7536.
8
Characterization of hepatitis C virus interaction with heparan sulfate proteoglycans.丙型肝炎病毒与硫酸乙酰肝素蛋白聚糖相互作用的表征
J Virol. 2015 Apr;89(7):3846-58. doi: 10.1128/JVI.03647-14. Epub 2015 Jan 21.
9
The Role of Heparanase and Sulfatases in the Modification of Heparan Sulfate Proteoglycans within the Tumor Microenvironment and Opportunities for Novel Cancer Therapeutics.肝素酶和硫酸酯酶在肿瘤微环境中修饰硫酸乙酰肝素蛋白聚糖中的作用及新型癌症治疗的机会。
Front Oncol. 2014 Jul 24;4:195. doi: 10.3389/fonc.2014.00195. eCollection 2014.
10
Heparan sulfate signaling in cancer.癌症中的硫酸乙酰肝素信号传导
Trends Biochem Sci. 2014 Jun;39(6):277-88. doi: 10.1016/j.tibs.2014.03.001. Epub 2014 Apr 19.